Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-29

Clinical Trial Update: Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study [NA]

View source ↗

Summary

A clinical trial testing a mobile intervention to improve adherence to oral anti-cancer medications in acute myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Acute Myeloid Leukemia | NA | Status: WITHDRAWN